Avricore Health Inc.
AVCR.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.47M | 3.30M | 2.95M | 2.58M | 2.30M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.47M | 3.30M | 2.95M | 2.58M | 2.30M |
| Cost of Revenue | 2.15M | 2.11M | 1.85M | 1.69M | 1.66M |
| Gross Profit | 1.32M | 1.19M | 1.09M | 890.40K | 646.20K |
| SG&A Expenses | 1.19M | 1.15M | 1.28M | 1.32M | 1.34M |
| Depreciation & Amortization | 1.90K | 1.90K | 2.00K | 1.70K | -75.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.34M | 3.26M | 3.14M | 3.02M | 2.92M |
| Operating Income | 126.60K | 40.30K | -192.00K | -436.20K | -619.50K |
| Income Before Tax | 77.00K | -4.20K | -255.30K | -521.90K | -746.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 0.08 | 0.00 | -0.26 | -0.52 | -0.75 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 77.00K | -4.20K | -255.30K | -521.90K | -746.00K |
| EBIT | 126.60K | 40.30K | -192.00K | -436.20K | -619.50K |
| EBITDA | 463.10K | 383.80K | 138.20K | -127.60K | -353.30K |
| EPS Basic | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 399.68M | 398.92M | 398.68M | 398.23M | 396.96M |
| Average Diluted Shares Outstanding | 405.41M | 404.66M | 398.68M | 398.23M | 396.96M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |